Oxford Biomedica (LON:OXB) Shares Cross Above 50-Day Moving Average – Here’s What Happened

Oxford Biomedica plc (LON:OXBGet Free Report)’s stock price passed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of GBX 421.03 ($5.27) and traded as high as GBX 427.50 ($5.35). Oxford Biomedica shares last traded at GBX 423 ($5.29), with a volume of 114,411 shares trading hands.

Wall Street Analysts Forecast Growth

Separately, Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Oxford Biomedica from GBX 250 ($3.13) to GBX 380 ($4.75) and gave the stock a “hold” rating in a research note on Tuesday, September 24th.

Check Out Our Latest Analysis on OXB

Oxford Biomedica Stock Down 0.5 %

The firm has a 50-day moving average of GBX 421.03 and a two-hundred day moving average of GBX 376.04. The firm has a market cap of £443.57 million, a price-to-earnings ratio of -292.36 and a beta of 1.09. The company has a current ratio of 2.35, a quick ratio of 1.67 and a debt-to-equity ratio of 154.88.

About Oxford Biomedica

(Get Free Report)

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.

Featured Articles

Receive News & Ratings for Oxford Biomedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Biomedica and related companies with MarketBeat.com's FREE daily email newsletter.